Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
Global - North America
Archived
•
October 22, 2026
•
Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.
Source: NYT Home Page | https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



